US Bancorp’s Zura Bio ZURA Stock Holding History

US Bancorp’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.88K	Hold	318	–	–	﹤0.01%	3882
2026 Q1	$1.89K	Buy	+318	New	+$1.92K	﹤0.01%	3813

Other funds holding ZURA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

US Bancorp's ZURA Position: Q2 2026 in Review

US Bancorp held its Zura Bio (ZURA) position steady in Q2 2026 at 318 shares worth $1.88K. The position accounts for ﹤0.01% of the portfolio, ranked #3882.

US Bancorp first reported a position in ZURA in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.89K in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

US Bancorp held 318 shares of Zura Bio worth $1.88K as of Q2 2026.
US Bancorp left its Zura Bio share count unchanged in Q2 2026.
Zura Bio made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3882 holding.
US Bancorp first reported a position in Zura Bio in Q1 2026 and has held it in 2 quarters since.
US Bancorp's Zura Bio position peaked at $1.89K in Q1 2026.
95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.